OncoSec Financial Statements From 2010 to 2024
| ONCSDelisted Stock | USD 0.06 0 3.63% |
Check OncoSec Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OncoSec Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . OncoSec financial statements analysis is a perfect complement when working with OncoSec Medical Valuation or Volatility modules.
OncoSec |
OncoSec Medical Company Return On Equity Analysis
OncoSec Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OncoSec Medical Return On Equity | -4.1 |
Most of OncoSec Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, OncoSec Medical has a Return On Equity of -4.1017. This is 82.89% lower than that of the Biotechnology sector and 88.75% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
OncoSec Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OncoSec Medical's current stock value. Our valuation model uses many indicators to compare OncoSec Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OncoSec Medical competition to find correlations between indicators driving OncoSec Medical's intrinsic value. More Info.OncoSec Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value OncoSec Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About OncoSec Medical Financial Statements
OncoSec Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although OncoSec Medical investors may analyze each financial statement separately, they are all interrelated. The changes in OncoSec Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on OncoSec Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |